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Abstract
Introduction: Vitamin D is vital in the regulation of the calcium-phosphate metabolism, has a direct impact on the musculoskeletal sys-
tem, and also affects numerous other systems. Widespread vitamin D deficiency and its detrimental effect on health have been reported 
globally. Data concerning vitamin D status in Polish adult population is scarce. 
Material and methods: Ambulatory patients of an outpatient clinic in Gdańsk were included in the study. Serum concentrations of 25(OH)
D, parathyroid hormone (PTH), alkaline phosphatase (ALP), calcium and phosphorus were determined. In a questionnaire declared 
UVB exposure, dietary vitamin D and calcium intake, and health status of the subjects were assessed. Non- and parametric tests, logistic 
regression and population attributable risk were applied in data analysis. 
Results: 448 adults were examined from February to mid-April 2012, 305 women and 143 men, aged 19 to 86 (mean 46.3 ± 14.9 years). 
Mean 25-hydroxyvitamin D concentration was 14.3 ± 6.6 ng/mL. 84.4% of subjects were vitamin D deficient (25(OH)D < 20 ng/mL); 13.2% 
presented insufficient (20–30 ng/mL), and 2.5% (or 11 subjects) sufficient 25(OH)D concentrations. 
Significantly higher 25(OH)D concentrations were found in subjects who reported more UVB exposure, supplemented vitamin D orally 
and those who declared more physical activity. 
21% of subjects had elevated serum PTH concentration (i.e. > 62 pg/mL); mean parathormone was 48.6 ± 25.2 pg/mL. A linear correlation 
was found between the logarithm of PTH and logarithm of 25(OH)D concentrations (r = –0.21, p < 0.001).
Conclusions: Results obtained here demonstrate the necessity of implementing a monitoring and prophylaxis programme of vitamin D 
deficiency in Poland. (Endokrynol Pol 2014; 65 (2): 105–113)
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Streszczenie
Wstęp: Witamina D pełni ważną funkcję w regulacji gospodarki wapniowo-fosforanowej, ma bezpośredni wpływ na układ mięśniowo-
-szkieletowy, a także oddziałuje na liczne, inne układy organizmu. Niedobór witaminy D i jego negatywny wpływ na stan zdrowia były i są 
wykazywane na całym świecie. Niewiele jest danych mówiących o stanie zaopatrzenia w witaminę D osób dorosłych z populacji polskiej. 
Materiał i metody: Do badania zrekrutowano osoby korzystające z ambulatoryjnych usług zakładu opieki zdrowotnej w Gdańsku, u których 
oznaczono surowicze stężenia 25(OH)D, parathormonu (PTH), fosfatazy alkalicznej (ALP), wapnia i fosforu. W kwestionariuszu oceniono 
ekspozycję na UVB, nawyki dietetyczne w zakresie podaży witaminy D i wapnia oraz stan zdrowia. Dane przeanalizowano za pomocą pa-
rametrycznych i nieparametrycznych testów statystycznych, logistycznej regresji i ryzyka przypisanego populacji (population attributable risk). 
Wyniki: Od lutego do połowy kwietnia 2012 roku przebadano 448 dorosłych: 305 kobiet i 143 mężczyzn w wieku 19–86 lat (średnia 46,3 
± 14,9 lat). Średnie stężenie 25-hydroksy-witaminy D wyniosło 14,3 ± 6,6 ng/ml; 84,4% badanych miało niedobór witaminy D (25(OH)
D < 20 ng/ml); 13,2% niedostateczne stężenie (20–30 ng/ml), a 2,5% (tj. 11 probantów) prawidłowe stężenie 25(OH)D. Istotnie wyższe 
stężenia 25(OH)D wykazano dla uczestników, którzy: przyjmowali preparaty witaminy D, mieli większą ekspozycję na promieniowanie 
UVB (opalanie na słońcu lub w solarium), a także podawali większą aktywność fizyczną. 21% probantów miało podwyższone (> 62 pg/ml) 
stężenie PTH przy wartości średniej dla wszystkich badanych 48.6 ± 25.2 pg/ml. Stwierdzono liniową zależność między logarytmem 
parathormonu a logarytmem 25(OH)D (r = –0.21, p < 0,001).
Wnioski: Otrzymane wyniki wskazują na konieczność opracowania programu monitoringu i profilaktyki hipowitaminozy D w Polsce. 
(Endokrynol Pol 2014; 65 (2): 105–113)
Słowa kluczowe: niedobór witaminy D; kalcyfediol; parathormon; światło słoneczne; promienie ultrafioletowe; nadwaga; dorosły
Introduction
Vitamin D is classically recognised as a crucial hormone 
in the calcium-phosphate metabolism, vital in the for-
mation and preservation of bone structure. However, 
evidence has been accumulating related to vitamin D’s 
effects on muscle function as well as on numerous other 
organs, tissues and systems [1, 2]. 
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Insufficient levels of vitamin D have been observed 
in populations of many countries, mainly due to insuf-
ficient exposure to sunlight and inadequate supplemen-
tation [1, 3, 4, 6]. Associations have also been reported 
between low serum vitamin D concentrations and an 
increased risk of numerous diseases, ranging from au-
toimmune, infectious, cardio-metabolic to neoplasmatic 
[1, 2, 5–7]. Research concerning the effects of vitamin 
D on both skeletal and non-skeletal health is ongoing. 
Vitamin D is a general name for several compounds 
categorised as secosteroids [8], however, two substan-
ces, cholecalciferol and ergocalciferol, are the specific 
compounds to which this term refers commonly [9]. 
The majority of vitamin D present in the human body 
is produced in the skin exposed to ultraviolet (type 
B, UVB) radiation (vitamin D3, cholecalciferol) while 
a smaller portion is obtained orally (vitamin D2, ergoc-
alciferol) [9]. A number of factors influence the endog-
enous synthesis of vitamin D, among them (as in the 
review paper by Engelsen): solar zenith angle, ozone 
layer, altitude, time spent outdoors, body area exposed 
to sun, as well as clothing and use of sunscreens [10]. 
It is universally accepted that vitamin D status is 
reflected by the concentration of serum 25-hydroxyvi-
tamin D, 25(OH)D, calcifediol, i.e. the most abundant 
circulating form of the vitamin [11]. There is, however, 
no consensus as to the reference values determining 
25(OH)D deficiency and sufficiency, in particular con-
sidering vitamin D’s nonskeletal effects [1, 2, 5, 13]. The 
proposed cut-off values — accepted by most authors - of 
sufficiency (25(OH)D > 30 ng/mL), insufficiency (20–30 
ng/mL) and deficiency (< 20 ng/mL) have been applied 
in our study (Table I). 
Data reflecting vitamin D status among Polish adults 
is insufficient. So far, the vast majority of studies have 
involved osteoporotic and elderly persons [14–17]. Also, 
to the best of our knowledge, the numbers studied in 
each study have not exceeded 300 subjects apart from 
the PolSenior project (and perhaps the study by Ho-
szowski et al.) [14, 15].
In this study, we aimed at determining serum cal-
cium-phosphate metabolism parameters, behavioural 
factors influencing vitamin D concentration, and health 
status of adults from the Pomeranian province during 
months of low UVB exposure. 
Material and methods
The consent of the independent bioethics committee 
of the Medical University of Gdańsk was obtained to 
perform this study. 
The project was performed from February to mid-
April 2012 to ascertain the lack of effective skin vitamin 
D synthesis during these months.
Study participants
Persons aged 18 and older who agreed to participate in 
the study were recruited. The participants were indi-
viduals who presented for vocational medicine visits, 
physician’s appointments and additional examinations 
in an outpatient clinic Endomed Medical Diagnostic 
Centre in Gdansk. There were no exclusion criteria. 
Each study participant received written information 
concerning the examinations and signed a consent 
form for them. 
Questionnaire examination
Each study participant filled out a questionnaire con-
cerning social characteristics, dietary habits related to 
vitamin D and calcium intake, exposure to UVB (from 
suntanning and sunbed tanning), health status, chronic 
medication and diseases. The questionnaire involved 
semi-quantitative and qualitative assessment of these 
factors.
In particular, the consumption frequency of vitamin 
D-rich foods was asked (fish, eggs); symptoms (muscle 
pain and weakness) and diseases associated with or 
leading to 25(OH)D deficiency were investigated. 
Laboratory examinations
Blood was drawn from participants and spun for ten 
minutes at 3,500 g after which plasma was transferred to 
a separate tube and subsequently frozen at –20°C. After 
transport of tubes in dry ice to the Central Diagnostic 
Laboratory of the Medical University of Gdańsk, serum 
concentrations of 25-hydroxyvitamin D, 25(OH)D, and 
parathyroid hormone (PTH) were determined using 
a chemiluminescence method (CLIA) with dedicated 
assays in, respectively, a DiaSorin® Liaison® analy-
ser (“25OH Vitamin D TOTAL” assay) and a Siemens 
IMMULITE® 1000 Immunoassay System. Alkaline 
phosphatase (ALP), calcium (Ca), phosphorus (P) con-
centrations were determined spectrophotometrically 
in an Abbott Architect® analyser.
Table I. Proposed 25(OH)D concentration ranges in adults
Tabela I. Proponowane zakresy stężęń 25(OH)D u dorosłych
25(OH)D [ng/mL] Clinical situation
≤ 10 Severe deficiency
10–20 Deficiency
20–30 Insufficiency
30–80 Sufficiency 
≥ 150 Toxicity
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Statistical analysis
Statistical evaluation was performed using STATIS-
TICA 10, StatsDirect version 2.7.2 (StatsDirect Ltd), 
R (http://www.r-project.org/) and Stata (StataCorp 
LP) software.
25(OH)D concentration values did not follow 
a Gaussian distribution (as verified in Kolmogorov-
Smirnov test with Lilliefors correction). Therefore, 
either a Box-Cox transformation was applied before 
performing comparisons with t-test, or non-parametric 
tests were used (depending on group size and expected 
values, chi-square with or without Yates correction, 
V-square or Fisher’s exact test) as has been indicated 
in legends. 
Uni- and multivariate analyses were performed to 
determine the probability of 25(OH)D concentration 
exceeding 20 ng/mL in the presence and/or absence of 
studied factor(s). Comparisons in univariate analysis 
for which the test power (1-β) exceeded 95% were con-
sidered significant. Multivariate analysis was performed 
by logistic regression (Quasi-Newton estimation). Con-
fidence intervals (CI) for odds ratios were established at 
95%. Population attributable risk (PAR) was calculated.
Significance level was set at 0.05. 
Results
448 adults were examined from February to mid-April 
2012, 305 women and 143 men, aged 19 to 86 (mean 
46.3 ± 14.5 years) (Table II). The vast majority of 
participants inhabited a highly urbanised area of the 
Pomeranian province in the north of Poland, i.e. the 
Tri-city (Gdańsk, Sopot and Gdynia) and its suburbs. 
Mean 25-hydroxyvitamin D concentration was 
14.3 ± 6.6 ng/mL and median 12.9 ng/mL. 84.4% of sub-
jects were vitamin D deficient (25(OH)D < 20 ng/mL) and 
13.2% insufficient (20–30 ng/mL) (Fig. 1, Table II). Only 
2.5% of subjects had 25(OH)D concentrations above 
30 ng/mL (sufficiency). 
According to the proposed 25(OH)D concentra-
tion ranges, four study participants subgroups were 
investigated. The vitamin D sufficiency (25(OH)D > 
30 ng/mL) group (group 4) consisted solely of women 
with a median age of 38 years (mean 39.2) which was 
significantly lower than the age of participants from 
the three other groups (as demonstrated in Table II). 
Furthermore, the median BMI (23.44 kg/m2) for these 
11 women differed significantly from that of other groups. 
Subjects were also divided into three age groups: 
19–39, 40–59, and 60 years and older. Significant dif-
ferences in 25-hydroxyvitamin D concentrations were 
found between: 
 — males and females aged 19-39 (mean concentrations: 
15.3 v. 13.3 ng/mL, p < 0.05); 
 — males aged 19-39 and eldest (13.3 v. 15.9 ng/mL, 
p < 0.05); 
 — youngest and eldest females (15.3 v. 13 ng/mL, 
p < 0.05) as shown in Table III. 
There was a highly significant difference in mean 
BMI values between genders in the under-40 and 
over-60 age group (22.4 v. 25.9, and 29.6 v. 25.6 kg/m2 
respectively) (Table III). 
Further, significantly higher 25(OH)D concentra-
tions were found in the following study participants 
(versus respective counterparts): subjects supplement-
ing vitamin D, those who reported more recent and 
more frequent sun and sunbed tanning, and more 
physical activity (Figs. 2A–F). Importantly, mean 25-hy-
droxyvitamin D concentration of participants who 
declared oral vitamin D supplementation was 16.1 ng/mL 
which indicates deficiency in the majority of these sub-
jects (86 out of 119) (Fig. 2A). Overall, declared frequent 
or recent episodes of UVB exposure have had a major 
impact on the 25(OH)D status. Strongest statistical dif-
ferences were found among subjects who claimed to 
have (sun and/or sunbed) tanned at least once weekly 
or after 1 October 2011 (Figs. 2B–E). 
Interestingly, fewer infections were stated by partici-
pants with higher vitamin D concentrations (Fig. 2G). 
The influence of examined factors on the probability 
of 25(OH)D exceeding 20 ng/mL was investigated in 
uni- and multivariate analysis (Table IV). Factors were 
arranged according to the strength of their prediction 
value. In univariate analysis, UVB exposure-related 
and vitamin D supplementation factors were posi-
tive predictors for the assumed 25-hydroxyvitamin D 
concentration. Multivariant analysis showed that only 
suntanning frequency, vitamin D supplementation and 
the date of last sunbed tanning were statistically signifi-
cant factors that were associated with the probability 
of 25(OH)D being higher than 20 ng/mL.
Interestingly, 21% of subjects had elevated PTH 
concentration, i.e. > 62 pg/mL, while mean parathyroid 
hormone was 48.6 ± 25.2 pg/mL. A linear correlation 
was found between the logarithm of PTH and logarithm 
of 25(OH)D concentrations (r = –0.21, p < 0.001) (Fig. 3).
Discussion
The 25-hydroxyvitamin D concentrations found here 
demonstrate its deficiency in the vast majority of sub-
jects. Similar data has been acquired in other studies 
involving white adults during months of low UVB 
exposure. 
In Webb et al.’s work, 109 ambulatory participants 
(85 female, 24 male, mean age 44 years, interquartile 
range, IQR, for age: 34–51, median BMI 24.9 kg/m2, 
IQR 22.7–28), living in the Greater Manchester region 
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Table II. Demographic, calcium-phosphate metabolism parameters, and chosen behavioural data according to 25(OH)D 
concentration range means with SDs or percentages and no of subjects
Tabela II. Dane demograficzne, wykładniki gospodarki wapniowo-fosforanowej i wybrane dane behawioralne w zależności 
od zakresów stężeń 25(OH)D średnie z OS albo odsetki i liczba badanych
Group (according to 25(OH)
D [ng/mL])
All subjects Group 1 
(< 10)
Group 2 
(10–20)
Group 3 
(20–30)
Group 4 
(> 30)
Significance level 
p
Number of  
subjects (%)
448 
(100%)
121 
(27%)
254 
(56.7%)
62 
(13.8%)
11 
(2.5%)
Age  
(years)
46.3  
(14.5)
46.4  
(15)
46 
(15)
49.1  
(14.3)
39.2 
(12.3)
0.04 
(gr. 4 v. 3)
BMI  
[kg/m2]
25.3 
(4.7)
25.7 
 (5.1)
25.5  
(4.7)
25.4  
(4.1)
23.4  
(4.9)
0.04 
(gr. 4 v. 1, 2 and 3)
Calcium-phosphate metabolism parameters
25(OH)D  
[ng/mL]
14.3  
(6.57)
7.88  
(1.65)
13.96  
(2.67)
24.44  
(2.99)
35.64  
(4.69)
< 0.0001
PTH  
[pg/mL]
48.6  
(25.2)
55.24  
(30.79)
47.29  
(22.79)
40.82  
(18.34)
43.60  
(25.28)
0.004 
(gr. 1 v. 3)
Calcium  
[mg/dL]
9.56  
(0.44)
9.52 
 (0.54)
9.56  
(0.46)
9.50  
(0.53)
9.41  
(0.35)
NS
Phosphorous 
[mg/dL]
3.49 
 (0.62)
3.51 
 (0.56)
3.48  
(0.67)
3.43  
(0.56)
3.58  
(0.32)
NS
ALP  
[IU/L]
67.6  
(23.8)
68.20  
(22.45)
67.04  
(25.32)
67.79  
(20.32)
59.00  
(16.13)
NS
Vitamin D supplementation
Vitamin D supplementation 26.6% 
[119]
24.8% 
[30]
22% 
[56]
43.5% 
[27]
54.5% 
[6]
0.001
Daily vitamin D 
supplementation
19.2% 
[86]
12.4% 
[15]
16.5% 
[42]
40.3% 
[25]
36.3% 
[4]
0.001
UVB exposure
Suntanning  
≥ 1 weekly
11.4% 
[51]
5% 
[6]
9.4% 
[24]
27.4% 
[17]
36.4% 
[4]
< 0.0001
Suntanning after 1st October 8.3% 
[37]
3.3% 
[4]
6.3% 
[16]
21% 
[13]
36.4% 
[4]
< 0.0001
Sunbed tanning ≥ 1 monthly 9.8% 
[44]
3.3% 
[4]
6.7% 
[17]
29% 
[18]
45.5% 
[5]
< 0.0001
Sunbed tanning after 1st 
October
4.2% 
[19]
0% 
[0]
2% 
[5]
16.1% 
[10]
36.4% 
[4]
< 0.0001
Sunscreen usage 55.1% 
[247]
57% 
[69]
53.5% 
[136]
58.1% 
[36]
54.5% 
[6]
NS
Lifestyle 
Physical activity ≥ 1 weekly 31.3% 
[140]
23.1% 
[28]
30.7% 
[78]
41.9% 
[26]
72.7% 
[8]
0.008
Non-smokers 68.5% 
[307]
71.1% 
[86]
66.9% 
[170]
69.4% 
[43]
72.7% 
[8]
NS 
Figure 1. 25(OH)D concentration versus age and sex. “Ο” and 
“Δ” point contours refer to women and men res pectively. Point 
fillings differentiate four vitamin D concentration ranges (< 10, 
10–20, 20–30, > 30 ng/mL)
Rycina 1. Stężenie 25(OH)D w zależności od wieku i płci. Punkty 
„Ο” i „Δ” oznaczają odpowiednio kobiety i mężczyzn. Wypełnienia 
punktów różnicują 4 zakresy stężeń 25(OH)D (< 10, 10–20, 
20–30, >30 ng/ml)
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A. 25(OH)D concentration and vitamin D supplementation; *p < 0.005 B. 25(OH)D concentration and date of suntanning. In the 
questionnaire, the date of last suntanning was asked. “1st October” 
refers to 1 October 2011. *p < 10–5; #p < 10–6; †p < 0.005 
(“never” v. “after 1st Oct”)
C. 25(OH)D concentration and suntanning frequency; *p < 0.0005, 
#p < 10-6, †p < 0.0005 (“never” v. “≥ 1 monthly”)
D. 25(OH)D concentration and date of sunbed tanning. In the 
questionnaire, the date of last sunbed tanning was asked. “1st 
October” refers to 1 October 2011. ; *p < 0.05; #p < 10–12
E. 25(OH)D concentration and sunbed tanning frequency; *p < 0.0005, 
#p < 10–11, †p < 10–6 (“never” v. “≥ 1 monthly”)
F. 25(OH)D concentration and frequency of physical activity; 
*p < 0.0005, #p < 10–11, †p < 10–6 (“never” v. “≥ 1 weekly”)
G. 25(OH)D concentration and infection susceptibility; Declared 
“low” infection susceptibility was no infections from November 2011, 
“high” — at least one infection per month; *p < 0.05 (“low” v. “high”)
Figure 2A–G. 25(OH)D and chosen behavioural factors. 
t-Student test was used to compare 25(OH)D between groups 
after applying Box-Cox transformation of 25(OH)D concentration 
values
Rycina 2A–G. Stężenie 25(OH)D w zależności od wybranych 
czynników behawioralnych. Do porównań między grupami użyto 
testu t Studenta po zastosowaniu transformacji Box-Coxa w 
odniesieniu do stężeń 25(OH)D. Wykresy przedstawiają średnie, 
słupki błędów — standardowe błędy średniej
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of the UK, (latitude 53.48° N; Gdańsk lies at 54.35° N) 
had lowest annual 25(OH)D concentrations in Febru-
ary: 18.3 ± 8.7 ng/mL, which is a comparable result to 
the one obtained here [18]. Apart from different study 
groups (elderly women were excluded by Webb et al.) 
vitamin D fortification may be one of the reasons for 
the difference in recorded concentrations. 
In Poland, a recent study included 132 citizens of 
Krakow (population about 760,000, 50.06°N): 82 females 
and 50 males aged 41–81 years (median 62 years) exam-
ined during “winter” [17]. Median 25(OH)D concen-
tration was 16.7 ng/mL and vitamin D deficiency was 
recorded in 90.2% of study participants. 
In another study, mean 25-hydroxyvitamin D con-
centration was 13.5 ng/mL for 274 women from Warsaw, 
aged 60-90 (mean 69.1 ± 4.7 years) and examined during 
“winter” [19]. 
Data presented here shows the vital effect of UVB 
exposure on vitamin D status. Despite insufficient UV 
radiation for cutaneous calcidiol synthesis during win-
ter in moderate geographic latitude regions [10, 20], the 
declared suntanning frequency may reflect the tissue 
Table III. Chosen data for all study participants and according to age-group and gender
Tabela III. Wybrane dane dla ogółu badanych i w zależności od grupy wiekowej i płci
Sex Both  
 
F M F M   F M F M 
Age group (years) – – – 19–39 40–59 60–86
Number of subjects  448 305 143 100 70 127 43 78 30
Age  
(years)
46.3 
(14.9)
48.1 
(14.5)
42.8 
(15.1)
31.2 
(5.2)
29.8 
(5.7)
50.2 
(6.2)
48.6 
(6.1)
66 
(5.3)
64.8 
(4.3)
25(OH)D  
[ng/mL]
14.3 
(6.6)
14.5 
(7.1) 
13.9 
(5.3)
15.3 
(7.9) 
13.3 
(5.2)* 
14.7 
(7.2) 
13.4 
(5)
13  
(5.6)†
15.9  
(5.4)‡ #
PTH 
[pg/mL]
48.6 
(25.2)
49.3 
(26.5)
44.1 
(22)
48.7 
(20.6)
56.9 
(18.1)
46.9 
(26.6)
42.1 
(27.5)
52.6 
(31.4)
50 
(19.4)
BMI 
[kg/m2]
25.8 
(4.7)
24.7 
(4.5)
27.3 
(4.8)
22.4 
(3.7)
25.9 
(3.6)**
25.4 
(4.6)
28 
(6)
26.5 
(4.1)
29.6  
(3.8)##
Vit. D supplementation  
(% subjects)
26.7 28.5 22.4 27 15.7 26 27.9 35.6 30
Daily vit. D 
supplementation 
(% subjects)
19.2 23 11.2 22 7.1 17.3 16.3 33.3 13.3
≥ 1 weekly vit. D 
supplementation 
(% subjects)
11.1 8.2 14.7 13 7.1 8.7 16.3 6.4 30
Suntanning (before  
or after 1st Oct) 
(% subjects)
34.8 40.7 22.4 45 14.3 42.5 30.2 47.2 30
Physical activity  
(% subjects)
86.4 85.9 87.4 90 91.4 81.9 83.7 87.2 83.3
“F” and “M” refer to women and men respectively. Age, 25(OH)D, PTH and BMI data are presented as “mean (standard deviation)”. Percentages of vitamin D 
supplementation, suntanning and physical activity were obtained by dividing subjects’ positive answers (i.e. “yes” with respect to vitamin D supplementation; 
suntanning date as opposed to “never”; physical activity frequency of at least once monthly v. “never”) by the number of subjects in a given group. T student test was 
used to compare 25(OH)D and BMI values between groups after applying Box-Cox transformation. Significance levels are as follows: * 25(OH)D in women v. men aged 
< 40 years: p < 0.05; ** BMI in women v. men in the < 40 years age group: p < 10–8; # 25(OH)D in women v. men in the over ≥ 60 years age group: p < 0.05; ## BMI 
in women v. men in the ≥ 60 years age group: p < 0.001; † 25(OH)D in women aged < 40 years v. women ≥ 60 years: p < 0.05; ‡ 25(OH)D in men aged < 40 years v. 
s men aged ≥ 60 years: p < 0.05
PTH — concentrations in pg/mL; 25(OH)D — concentrations 
in ng/mL; ln — natural logarithm. “Ο” and “Δ” point contours 
denote women and men respectively. Black point filling denotes 
subjects with PTH concentration higher than 62 ng/mL, i.e. upper 
reference limit (ln62 = 4.13)
Figure 3. Correlation between logarithms of 25(OH)D and 
parathyroid hormone. Spearman rank correlation coefficient 
r = –0.21, p < 0.001
Rycina 3. Korelacja między logarytmami stężeń witaminy 
D i parathormonu. Współczynnik korelacji rang Spearmana 
r = –0,21, p < 0,001
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stores of 25(OH)D acquired during earlier months [9]. 
Based on the results obtained here, it seems sunbed 
tanning provides an effective vitamin D synthesis 
source (the date of last sunbed usage was shown to be 
significant in multivariate analysis). 
Similarly to our results, previous studies have also 
reported correlations between 25(OH)D and PTH 
concentrations. In the above-mentioned works, weak 
correlations were found between plasma concentra-
tions of the two hormones: correlation coefficients were 
–0.13 and –0.23 (p < 0.007) in papers by (respectively) 
Napiórkowska et al., and Trofimiuk-Muldner, Kieć-
Klimczak and Hubalewska-Dydejczyk [17, 19]. An 
analogous trend was recorded by Pilz et al. (subjects 
were hypertensive adult patients examined not only 
in winter at 47° north latitude): in their work the dis-
cussed coefficient was –0.17 (p = 0.07) [21]. As Thacher 
and Clarke state in their review paper: “In adults, mul-
tiple cross-sectional examinations of the relationship 
between serum PTH and 25(OH) levels demonstrate 
a plateau in suppression of PTH when 25(OH)D level 
reaches approximately 30 ng/mL.” [2]. 
Also, factors associated here with higher 25(OH)
D concentrations such as UVB exposure (both natural 
and artificial) as well as physical exercise have been 
well-established [2, 22–24]. Concerning the incidence 
of infections, further studies are necessary to ascertain 
the consequences of given vitamin D status with sus-
ceptibility to them. 
In respect of age group and gender comparisons, 
several significant differences in 25(OH)D levels were 
found. 
Mean 25-hydroxyvitamin D concentration was 
lower in young (aged < 40 years) men compared to 
women, while their BMI was significantly higher. The 
latter result is most probably one of the explanations 
of the former one, since adiposity “is a risk factor for 
low 25(OH)D” [22]. However, the reported sun tanning 
date probably had a greater influence on this difference 
between the genders: 14.3% of men and 45% of women 
declared to have tanned. Further, a higher percentage 
of females reported vitamin D supplementation (27% 
v. 15.7%). 
Young males recruited here also had lower 25(OH)D 
concentration than men aged 60+. This result contrasts 
with the generally acknowledged notion that older 
age is a risk factor for vitamin D deficiency, mainly 
due to decreased cutaneous vitamin D synthesis [24]. 
An example of this are women examined in this study 
(young females versus elderly). The explanation might 
be that older male participants use more vitamin D sup-
plementation and actual sun exposure is significantly 
higher in this group, while young males spend little 
time outside. 
Finally, the difference between 25(OH)D concentra-
tions in elderly men and women found here has been 
previously reported [23]. In our study, men had higher 
25(OH)D levels despite higher mean BMI values (Table 
III). As suggested by Janssen et al., possibly hormonal 
changes due to menopause and/or actual time spent 
outdoors by men (despite similar ‘suntanning’ declara-
tions) explain these observations [23]. 
Results acquired here are a vital input to the cur-
rent state of knowledge concerning vitamin D status in 
Poland among non-elderly (only 56 participants were 
65 and older) and non-osteoporotic adults (33 subjects 
declared this diagnosis in the questionnaire, 22 of them 
were women aged 60 and over). 
However, several limitations need to be considered 
when interpreting the results. Firstly, the participants in 
this study by no means represent a model of the Polish 
adult population: almost all live in the agglomeration 
area of Tri-city in Poland (73.9% in either Gdańsk, popu-
lation ca. 456,000, Gdynia, 250,000 inhabitants, or Sopot, 
40,000), 68.1% were female, 42.2% were aged 19-39, all 
used the services of a private outpatient clinic. Also, it 
is unknown whether participants were suffering from 
diseases apart from those mentioned in the question-
naire (past fractures, osteoporosis, diabetes mellitus, 
multiple sclerosis, rheumatoid arthritis, asthma, sar-
coidosis, Crohn’s disease, depression, psoriasis, cancers, 
“liver disease”, irritable bowel syndrome and “digestive 
tract diseases”). 
Secondly, the methodology of acquiring informa-
tion concerning dietary vitamin D and calcium in-
take was semi-quantitative only, i.e. the frequency of 
a particular food type was asked per week or month. 
It was, therefore, impossible to estimate the ingested 
vitamin D amount, although, since foods in Poland are 
not fortified with the vitamin, there is little chance that 
it could be significant. The same disadvantage of the 
questionnaire holds for vitamin D supplementation: 
no doses were obtained. 
Thirdly, renal function was not evaluated concomi-
tantly to laboratory examinations, which makes it im-
possible to exclude secondary hyperparathyroidism due 
to renal disease for subjects with increased PTH concen-
tration. On the other hand, only 18 study participants 
reported to have and/or to have had “kidney disease” 
(only one of these had increased PTH concentration), 
while 428 responded negatively to this question. This 
makes it highly unlikely kidney disease caused elevated 
PTH levels in our participants. 
There are also a number of vital, strong points of 
the study. Importantly, 326 of all 448 subjects assessed 
their general health as “very good” (98 persons) and 
“fair” (226) rather than “satisfactory” (100) or “bad” 
(8). Despite this positive (subjective) assessment, most 
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of them were vitamin D deficient. Data such as this 
presented here is scarce for the Polish adult population. 
Further, results indicate insufficient vitamin D sup-
plementation, since the majority of those who stated 
it were 25(OH)D deficient or insufficient (their mean 
25(OH)D was 16.1 ± 7.9 ng/mL). 
Also, based on our findings, it is clear vitamin D 
deficiency must be considered a viable cause of elevated 
parathyroid hormone concentrations. 
Finally, it might be possible to extrapolate the ac-
quired results to other regions of Poland. While the 
participants enrolled here lived in the Pomeranian 
province (54.2° northern latitude), the blood sample 
collection was performed during months of insignifi-
cant skin vitamin D production not only in northern 
Poland but also in other areas of the country. Such an 
assumption can be drawn from the results of the study 
by Webb, Kline and Holick (1988) in which sunlight 
exposure was insufficient for vitamin D synthesis both 
in Boston (42.2°N) and Edmonton (52°N) from October 
to April [20]. On the other hand, in another study, a six 
degree latitude difference (Scotland, 51° and 57°) was 
associated with significant 25(OH)D concentration dif-
ferences both in winter and summer [25]. 
Conclusions 
The presented results demonstrate widespread vita-
min D deficiency among predominantly urban adults 
during winter months in the Pomeranian province in 
Poland, inappropriate vitamin D supplementation, and 
the importance of 25(OH)D status assessment in the 
differential diagnosis of hyperparathyroidism. 
A monitoring and prophylaxis programme of hy-
povitaminosis D in Poland should be implemented to 
ensure all potential health benefits of optimal vitamin 
D status.
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